EXEL
Exelixis Inc
Price:  
58.16 
USD
Volume:  
1,979,732.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL Relative Valuation

52.0%
Upside

As of 2026-09-27, the Relative Valuation of Exelixis Inc (EXEL) is 88.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.16 USD, the upside of Exelixis Inc based on Relative Valuation is 52.0%.

The range of the Relative Valuation is 76.97 - 104.15 USD.

Range Selected
Trailing P/E multiples 23.2x - 30.4x 28.0x
Forward P/E multiples 24.0x - 25.9x 25.2x
Fair Price 76.97 - 104.15 88.41
Upside 32.3% - 79.1% 52.0%
58.16 USD
Stock Price
88.41 USD
Fair Price

EXEL Relative Valuation - Historical P/E Data

Date P/E
2026-09-25 16.99
2026-09-24 16.93
2026-09-23 16.57
2026-09-22 16.98
2026-09-21 16.71
2026-09-18 17.05
2026-09-17 17.08
2026-09-16 16.58
2026-09-15 16.62
2026-09-14 16.42
2026-09-11 16.39
2026-09-10 16.77
2026-09-09 17.04
2026-09-08 16.84
2026-09-04 17.23
2026-09-03 17.27
2026-09-02 17.09
2026-09-01 16.62
2026-08-31 15.96
2026-08-28 15.90
2026-08-27 16.14
2026-08-26 16.38
2026-08-25 16.57
2026-08-24 15.93
2026-08-21 15.80
2026-08-20 15.68
2026-08-19 15.89
2026-08-18 15.51
2026-08-17 15.28
2026-08-14 14.97
2026-08-13 14.78
2026-08-12 14.71
2026-08-11 14.99
2026-08-10 15.47
2026-08-07 15.79
2026-08-06 15.25
2026-08-05 16.56
2026-08-04 16.36
2026-08-03 16.08
2026-07-31 15.49
2026-07-30 16.35
2026-07-29 16.16
2026-07-28 16.50
2026-07-27 16.30
2026-07-24 16.17
2026-07-23 16.25
2026-07-22 16.06
2026-07-21 16.39
2026-07-20 16.22
2026-07-17 16.33